Biologic therapies have revolutionized the treatment of chronic inflammatory diseases over the last two decades. Among these, ustekinumab has stood out as a highly effective monoclonal antibody targeting immune-mediated disorders. With the growing interest in affordability and access, ustekinumab biosimilar FDA approval has become a highly discussed topic in the medical and pharmaceutical community. Understanding …
Introduction Travoprost eye drops are a widely used ophthalmic medication, employed to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Elevated intraocular pressure is a major risk factor for optic nerve damage and progressive vision loss, making early and effective treatment essential. Travoprost eye drops belong to the prostaglandin analog …
Linaclotide is a commonly prescribed medication for digestive disorders that involve chronic constipation. While many patients experience significant relief, it is essential to clearly understand what are the side effects of linaclotide before starting or continuing treatment. Awareness of both mild and serious side effects can help patients avoid complications and use the medication safely. …
Complicated urinary tract infections (cUTIs) have remained a significant challenge in hospitals and clinical settings, especially with the rise of antimicrobial resistance (AMR). Patients with structural abnormalities, indwelling catheters, or comorbidities often struggle with infections that do not respond to standard oral antibiotics. In this escalating crisis, Contepo, an innovative antibacterial therapy, has emerged as …
Introduction Autoimmune disorders continue to increase worldwide, affecting millions of individuals with diseases such as myasthenia gravis (MG), immune thrombocytopenia (ITP), CIDP, and pemphigus. Traditional treatments such as corticosteroids, immunosuppressant’s, and biologics often result in relapses or serious side effects. In 2025, efgartigimod alfa-fcab has emerged as a game-changing biologic that is reshaping how healthcare …
Multiple myeloma (MM) is one of the most challenging blood cancers to treat—especially in patients who relapse after multiple treatments. In recent years, treatment options such as proteasome inhibitors, IMIDs, monoclonal antibodies, and CAR-T therapy have extended the lives of patients. However, the disease almost always returns. This is where Melflufen (melphalan flufenamide) plays an …
Introduction Cancer treatment has advanced dramatically in the past decades. Rather than relying on traditional chemotherapy – which indiscriminately kills rapidly dividing cells – new drugs target specific molecular pathways that tumor cells use to survive, grow, invade, and evade the immune system. One of the most promising innovations in this field is zanzalintinib, a …
Elahere (mirvetuximab soravatansine-ginx) is a pioneering antibody-drug conjugate (ADC) approved for platinum-resistant ovarian cancer, particularly in patients whose tumors express FRα (folate receptor-alpha). While this breakthrough therapy offers new hope, it also addresses some important safety concerns. This detailed guide explains the Elahere side effects , their frequency, severity, why they occur, how to monitor …
Introduction The field of oncology has evolved dramatically in recent years, with the introduction of targeted therapies that offer improved outcomes with fewer side effects. Among these revolutionary therapeutic agents, pirtobrutinib stands out as a next-generation Bruton tyrosine kinase (BTK) inhibitor that offers new hope for patients battling advanced B-cell malignancies. The pirtobrutinib approval has …
Epcoritamab – an advanced immunotherapy used in certain B-cell lymphomas – offers hope to many patients. But like many powerful treatments, it has a spectrum of side effects. Fully understanding the Epcoritamab Side Effects can help patients and caregivers stay informed, respond promptly to concerns, and increase safety while getting the most out of therapy. …
